0001127602-12-027241.txt : 20120927 0001127602-12-027241.hdr.sgml : 20120927 20120927180751 ACCESSION NUMBER: 0001127602-12-027241 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120926 FILED AS OF DATE: 20120927 DATE AS OF CHANGE: 20120927 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jones Trevor M CENTRAL INDEX KEY: 0001298861 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10269 FILM NUMBER: 121114123 MAIL ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALLERGAN INC CENTRAL INDEX KEY: 0000850693 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 951622442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 7142464500 MAIL ADDRESS: STREET 1: P.O. BOX 19534 CITY: IRVINE STATE: CA ZIP: 92713-9534 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2012-09-26 0000850693 ALLERGAN INC AGN 0001298861 Jones Trevor M 2525 DUPONT DRIVE IRVINE CA 92612 1 Common Stock 2012-09-26 4 S 0 1500 91.92 D 17327 D Common Stock 2012-09-26 4 M 0 1000 60.60 A 18327 D Common Stock 2012-09-26 4 S 0 1000 91.92 D 17327 D Nonemployee Director Stock Option (Right to Buy) 60.60 2012-09-26 4 M 0 1000 0 D 2017-05-01 Common Stock 1000 7400 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 10, 2012. Includes 4,800 shares of the Issuer's common stock underlying the RSUs awarded. Includes shares issued pursuant to the dividend equivalent rights, exempt transaction under Rule 16a-11. Option is fully vested and exercisable on the date of the next regular annual meeting of stockholders of Allergan, Inc. at which directors are to be elected following the date of grant. /s/ Matthew J. Maletta, Attorney-in-Fact for Trevor M. Jones 2012-09-27